Where does Edwards Lifesciences Innovation (Israel) Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Edwards Lifesciences Innovation (Israel) Ltd. ranks #9,750 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Edwards Lifesciences Innovation (Israel) Ltd. hold?

Edwards Lifesciences Innovation (Israel) Ltd. holds 32 US utility patents granted between 2023 and 2025, spanning 5 technology areas.

What is Edwards Lifesciences Innovation (Israel) Ltd.'s Innovation Score?

Edwards Lifesciences Innovation (Israel) Ltd. has an Innovation Score of 53.3 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Edwards Lifesciences Innovation (Israel) Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Edwards Lifesciences Innovation (Israel) Ltd..

What does claim depth mean for Edwards Lifesciences Innovation (Israel) Ltd.'s patents?

Edwards Lifesciences Innovation (Israel) Ltd.'s patents average 22.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Edwards Lifesciences Innovation (Israel) Ltd.

Q: What technology areas does Edwards Lifesciences Innovation (Israel) Ltd. focus on?

Edwards Lifesciences Innovation (Israel) Ltd.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 28 patents, ranking #234 of 3,082 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Q: How is the Edwards Lifesciences Innovation (Israel) Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 32 granted patents across 5 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Edwards ranks #9,750 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 5 technology areas.

#9,750
of 49,997 US assignees by volume: Top 9%
by Innovation Score (53.3/100): 22.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R9750 · Foreign Corporation #9,750 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 32 grants
UPPER-Q #9,750/49,997
PHOTO-FINISH Edwards Vacuum
CPC-NARROW A61F · 5 areas
INNOV-PAR 53.3/100
CLAIMS-DENSE 22.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Edwards Vacuum LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Edwards’s 53.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.1 pts (23%) Velocity 20.0 pts (38%) Breadth 7.9 pts (15%) Claim depth 13.3 pts (25%)

Qualcomm Incorporated · highest

85
ACM Research… · near

53
Berg Companies · near

53
Edwards Lifesciences… · this assignee

53
Lion Group · near

53
Quantum Valley… · near

53
3D Lighting… · lowest

7

What this shows Edwards's Innovation Score is 53.3/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Edwards?

Each dot is one of Edwards’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Edwards’s own 22.2 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Edwards vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Edwards's grants concentrate

Edwards Lifesciences Innovation (Israel) Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 87.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (11 grants) versus a trough of 9 in 2024. By volume, Edwards sits between Endospan Ltd. and Envision Energy (Denmark) ApS.

Edwards's three-year grant acceleration

Edwards Lifesciences Innovation (Israel) Ltd. shows 20 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Endospan

32
ETS Express

32
ETS Lindgren

32
Eurofilters Holdi…

32
Edwards Vacuum

32
Eko Sport

32
Energy Vault

32
Envision Energy (…

32
Edwards Lifescien… ◀

32

What this shows Edwards holds 32 patents at rank #9,756, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Edwards

By rank, the assignees closest to #9,756 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Edwards's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Edwards, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Edwards ranks #234 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Quantum Valley Ideas Laboratories 53 Lion Group, Inc. 53 ACM Research (SHANGHAI), Inc. 53 Berg Companies, Inc. 53

Edwards's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Edwards Lifesciences Innovation (Israel) Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	11	34.4%
2024	9	28.1%
2025partial year	12	37.5%

Which technologies does Edwards Lifesciences Innovation (Israel) Ltd. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 28

A61B - DIAGNOSIS; SURGERY; Identification 26

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 2

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Edwards Lifesciences Innovation (Israel) Ltd.'s patent record in context - here's where to go next.

Edwards Lifesciences Innovation (Israel) Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 87.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #9,750 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Edwards Lifesciences Innovation (Israel) Ltd. against Endospan Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 53.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.